Kuse R - Search Results

1

Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative Group.

Kern W, Aul C, Maschmeyer G, Kuse R, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W. Kern W, et al. Among authors: kuse r. Ann Hematol. 1998 Sep;77(3):115-22. doi: 10.1007/s002770050425. Ann Hematol. 1998. PMID: 9797080 Clinical Trial.

2

[Alternatives and further development of therapy of acute myeloid leukemia in adults. Update of West German multicenter studies].

Büchner T, Urbanitz D, Hiddemann W, Koch P, Pielken HJ, Kuse R, Mohr A, Maschmeyer G, Kreutzmann H, Wendt F, et al. Büchner T, et al. Among authors: kuse r. Onkologie. 1987 Feb;10(1):14-6. doi: 10.1159/000216360. Onkologie. 1987. PMID: 3295620 Clinical Trial. German.

3

Adult AML: the role of chemotherapy intensity and duration. Two studies of the AML Cooperative Group.

Büchner T, Hiddemann W, Blasius S, Koch P, Maschmeyer G, Tirier C, Sodomann H, Kuse R, Thiel E, Ludwig WD, et al. Büchner T, et al. Among authors: kuse r. Haematol Blood Transfus. 1990;33:261-6. doi: 10.1007/978-3-642-74643-7_47. Haematol Blood Transfus. 1990. PMID: 2182419 Clinical Trial. No abstract available.

4

Improved outcome in adult B-cell acute lymphoblastic leukemia.

Hoelzer D, Ludwig WD, Thiel E, Gassmann W, Löffler H, Fonatsch C, Rieder H, Heil G, Heinze B, Arnold R, Hossfeld D, Büchner T, Koch P, Freund M, Hiddemann W, Maschmeyer G, Heyll A, Aul C, Faak T, Kuse R, Ittel TH, Gramatzki M, Diedrich H, Kolbe K, Fuhr HG, Fischer K, Schadeck-Gressel C, Weiss A, Strohscheer I, Metzner B, Fabry U, Gökbuget N, Völkers B, Messerer D, Uberla K. Hoelzer D, et al. Among authors: kuse r. Blood. 1996 Jan 15;87(2):495-508. Blood. 1996. PMID: 8555471 Free article.

5

Postinduction and preremission chemotherapy alternatives for adult AML: three multicenter studies of the AML Cooperative Group.

Büchner T, Hiddemann W, Urbanitz D, Kreutzmann H, Maschmeyer G, Wendt F, Kuse R, Mohr A, Gassmann W, Löffler H, et al. Büchner T, et al. Among authors: kuse r. Haematol Blood Transfus. 1987;30:57-63. doi: 10.1007/978-3-642-71213-5_10. Haematol Blood Transfus. 1987. PMID: 3305221 Clinical Trial.

6

[Acute myeloid leukemia (AML) in adults. Further development of therapy based on clinical phase II and phase III studies].

Büchner T, Urbanitz D, Hiddemann W, Koch P, Pielken HJ, Kuse R, Mohr A, Maschmeyer G, Kreutzmann H, Wendt F, et al. Büchner T, et al. Among authors: kuse r. Onkologie. 1986 Apr;9(2):83-91. doi: 10.1159/000215970. Onkologie. 1986. PMID: 3520426 Clinical Trial. German.

7

Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.

Büchner T, Urbanitz D, Hiddemann W, Rühl H, Ludwig WD, Fischer J, Aul HC, Vaupel HA, Kuse R, Zeile G, et al. Büchner T, et al. Among authors: kuse r. J Clin Oncol. 1985 Dec;3(12):1583-9. doi: 10.1200/JCO.1985.3.12.1583. J Clin Oncol. 1985. PMID: 3906048 Clinical Trial.

8

Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.

Hehlmann R, Berger U, Pfirrmann M, Hochhaus A, Metzgeroth G, Maywald O, Hasford J, Reiter A, Hossfeld DK, Kolb HJ, Löffler H, Pralle H, Queisser W, Griesshammer M, Nerl C, Kuse R, Tobler A, Eimermacher H, Tichelli A, Aul C, Wilhelm M, Fischer JT, Perker M, Scheid C, Schenk M, Weiss J, Meier CR, Kremers S, Labedzki L, Schmeiser T, Lohrmann HP, Heimpel H; German CML-Study Group. Hehlmann R, et al. Among authors: kuse r. Leukemia. 2003 Aug;17(8):1529-37. doi: 10.1038/sj.leu.2403006. Leukemia. 2003. PMID: 12886239 Clinical Trial.

9

Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia.

Gahn B, Brittinger G, Dölken G, Döhner H, Emmerich B, Franke A, Freund M, Huber C, Kuse R, Scholten T, Hiddemann W. Gahn B, et al. Among authors: kuse r. Leuk Lymphoma. 2000 Mar;37(1-2):169-73. doi: 10.3109/10428190009057641. Leuk Lymphoma. 2000. PMID: 10721782 Clinical Trial.

10

Treatment of relapsed or refractory adult acute lymphocytic leukemia.

Freund M, Diedrich H, Ganser A, Gramatzki M, Heil G, Heyll A, Henke M, Hiddemann W, Haas R, Kuse R, et al. Freund M, et al. Among authors: kuse r. Cancer. 1992 Feb 1;69(3):709-16. doi: 10.1002/1097-0142(19920201)69:3<709::aid-cncr2820690318>3.0.co;2-g. Cancer. 1992. PMID: 1730121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters